Megumi Kitami

Megumi Kitami

Auto-generated profile, based on publicly available information

Megumi Kitami

Center for Advanced Oral Science, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan; Division of Dental Pharmacology, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2018 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
JRJuan Marcelo Rosales Rocabado
Juan Marcelo Rosales Rocabado
MKMasaru Kaku
Masaru Kaku
KNKosuke Nozaki
Kosuke Nozaki
TITakako Ida
Takako Ida
MKMegumi Kitami
Megumi Kitami
KUKatsumi Uoshima
Katsumi Uoshima
Postmenopausal osteoporosis develops due to a deficiency of estrogen that causes a decrease in bone mass and changes in the macro- and micro-architectural structure of the bone, leading to the loss of mechanical strength and an increased risk of fracture. Although the assessment of bone mineral density (BMD) has been widely used as a gold standard for diagnostic screening of bone fracture risks, it accounts for only a part of the variation in bone fragility; thus, it is necessary to consider other determinants of bone strength. Therefore, we aimed to comprehensively evaluate the architectural changes of the bone that influence bone fracture strength, together with the different sensitivities of cortical and trabecular bone in response to ovariectomy (OVX). Bone morphology parameters were separately analyzed both in cortical and in trabecular bones, at distal-metaphysis, and mid-diaphysis of OVX rat femurs. Three-point bending test was performed at mid-diaphysis of the femurs. Correlation of OVX-induced changes of morphological parameters with breaking force was analyzed using Pearson’s correlation coefficient. OVX resulted in a decline in the bone volume of distal-metaphysis trabecular bone, but an increase in distal-metaphysis and mid-diaphysis cortical bone volume. Tissue mineral density (TMD) remained unchanged in both the trabecular and cortical bone of the distal metaphysis but decreased in cortical bone of the mid-diaphysis. The OVX significantly increased the breaking force at mid-diaphysis of the femurs. OVX decreased the trabecular bone volume of the distal-metaphysis and increased the cortical bone volume of the distal-metaphysis and mid-diaphysis. Despite the reduction in TMD and increased cortical porosity, bone fracture strength increased in the mid-diaphysis after OVX. These results indicate that analyzing a single factor, i.e., BMD, is not sufficient to predict the absolute fracture risk of the bone, as OVX-induced bone response vary, depending on the bone type and location. Our results strongly support the necessity of analyzing bone micro-architecture and site specificity to clarify the true etiology of osteoporosis in a clinical setting.

12 April 2024 in ESMO Open
Verified
Journal Article
Open access
TKTakashi Kubo
Takashi Kubo
KSKuniko Sunami
Kuniko Sunami
TKTakafumi Koyama
Takafumi Koyama
MKM. Kitami
M. Kitami
YFY. Fujiwara
Y. Fujiwara
NYN. Yamamoto
N. Yamamoto
Comprehensive genome profiling (CGP) serves as a guide for suitable genomically matched therapies for patients with cancer. However, little is known about the impact of the timing and types of cancer on the therapeutic benefit of CGP. A single hospital-based pan-cancer prospective study (TOP-GEAR; UMIN000011141) was conducted to examine the benefit of CGP with respect to the timing and types of cancer. Patients with advanced solid tumors (>30 types) who either progressed with or without standard treatments were genotyped using a single CGP test. The subjects were followed up for a median duration of 590 days to examine therapeutic response, using progression-free survival (PFS), PFS ratio, and factors associated with therapeutic response. Among the 507 patients, 62 (12.2%) received matched therapies with an overall response rate (ORR) of 32.3%. The PFS ratios (≥1.3) were observed in 46.3% (19/41) of the evaluated patients. The proportion of subjects receiving such therapies in the rare cancer cohort was lower than that in the non-rare cancer cohort (9.6% and 17.4%, respectively; P = 0.010). However, ORR of the rare cancer patients was higher than that in the non-rare cancer cohort (43.8% and 20.0%, respectively; P = 0.046). Moreover, ORR of matched therapies in the first or second line after receiving the CGP test was higher than that in the third or later lines (62.5% and 21.7%, respectively; P = 0.003). Rare cancer and early-line treatment were significantly and independently associated with ORR of matched therapies in multivariable analysis (P = 0.017 and 0.004, respectively). Patients with rare cancer preferentially benefited from tumor mutation profiling by increasing the chances of therapeutic response to matched therapies. Early-line treatments after profiling increase the therapeutic benefit, irrespective of tumor types.


11 November 2025 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
LTLay Thant
Lay Thant
ADAzusa Dobashi
Azusa Dobashi
MKMegumi Kitami
Megumi Kitami
HPHlaing Pwint Phyu
Hlaing Pwint Phyu
MKMizuki Kobayashi
Mizuki Kobayashi
MKMasaru Kaku
Masaru Kaku
The extracellular matrix (ECM) plays a crucial role in tissue structure and function and serves as an integral component of diverse biological systems. However, the comprehensive characterization of ECM components is challenging because of the insoluble nature of highly cross-linked and glycosylated ECM proteins. This study introduces a chemical digestion-assisted proteomic approach to overcome challenges in ECM profiling, offering an in-depth analysis of the human periodontal ligament (PDL), a tissue critical for oral function and regeneration. Furthermore, we investigated alterations in the ECM composition of cultured PDL cells to provide insights relevant to tissue engineering applications. Our protocol combined chemical digestion and deglycosylation to enhance the identification of ECM proteins. Chemical digestion by hydroxylamine improved protein extraction efficiency by approximately two-fold compared to conventional chaotropic extraction, and deglycosylation increased the number of identified ECM proteins without substantially altering the ECM profile, offering robust quantification of ECM components. A sequential protein extraction approach revealed that proteins insoluble by conventional methods are primarily composed of highly cross-linked fibrillar collagen. Through the application of this technique to human PDL tissue, we present a comprehensive ECM profile for the first time, revealing a high collagen content (> 80%) and identifying dominant non-collagenous ECM proteins, such as periostin, dermatopontin, and lumican. Our findings highlight the significant differences between the native ECM of PDL tissue and that produced by cultured PDL cells, emphasizing the importance of considering these variations in regenerative strategies. This study offers a robust tool for analyzing the ECM and its dynamics across diverse tissues and under various physiological and pathological conditions. The results enhance our understanding of periodontal tissue and will inform future approaches for periodontal tissue regeneration.